Regional News
OriCell Therapeutics Raises Over $120 Million in Series B Financing Led by Qiming Venture Partners and Quan Capital to Advance Cell Therapies for Cancer Immunology
2022 is set to be a milestone year for OriCell who has been focusing on the
field of cancer immunotherapy for more than seven years and is fully committed
to becoming an innovative global drug developer.
SHANGHAI, Aug. 1, 2022 /PRNewswire/ -- OriCell Therapeutics
"OpenDEL®3.0 - DRUG DISCOVERY PARTNER" webinar offered by HitGen and Endpoints News coming up on Thursday 4th August
CHENGDU, China, Aug. 1, 2022 /PRNewswire/ -- "OpenDEL®3.0 – DRUG DISCOVERY PARTNER" webinar will be jointly held by HitGen Inc. and Endpoints News on Thursday 4th August, to present you with a high-quality DEL product with all DEL information sharing and technical support. Dr. Guansai Liu, Execut...
Powerbridge Technologies Co., Ltd. Regains Compliance with Nasdaq's Minimum Bid Price Rule
ZHUHAI, China, Aug. 1, 2022 /PRNewswire/ -- Powerbridge Technologies Co., Ltd. (Nasdaq: PBTS) ("Powerbridge" or the "Company"), a provider of multi-industry technology solutions, announced that it has regained compliance with the minimum bid price requirement under the continued listing requireme...
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
* GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities * Technology transfer and scale-up from lab bench to Samsung's commercial facility was completed in seven months * GreenLight's mRNA synthesis reaction had a titer of 12g/L at a commer...
Yunji's Technology-empowered Private Label SUYE Celebrates Its 12th Anniversary
HANGZHOU, China, Aug. 1, 2022 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced the celebration of its private-label skin care brand SUYE's 12th anniversary. SUYE generated over21 million RMB sales of its hig...
New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome--Published in Clinical Cancer Research
* Recent clinical trial on combination immunotherapy for nasopharyngeal cancer provides evidence for Lunit SCOPE IO's ability to predict patient response. * Analysis indicates Immune-excluded Immune Phenotype acts as a resistance mechanism against combination immunotherapy, further supporting...
Boqii Provides Update on its Status under the Holding Foreign Companies Accountable Act
SHANGHAI, Aug. 1, 2022 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE: BQ), a leading pet-focused platform inChina, today provides an update on its status under the Holding Foreign Companies Accountable Act (the "HFCAA"). The Company is aware that it has been identified b...
Bon Natural Life Limited Announces Record First Half-Year Revenue and Net Income
1H-2022 Revenue increases by 17.0% to $13.7 million XI'AN, China, Aug. 1, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-year...
Hainan Li Brocade Fashion Show Attracts Attention at the China International Consumer Products Expo
HAIKOU, China, Aug. 1, 2022 /PRNewswire/ -- On July 30, at the China International Consumer Products Expo 2022 inHainan, China, a fashion show with the theme of "Li Brocade Weaving Mountains and Seas" held by Changjiang Li Autonomous County,Hainan, brought a refreshing experience to Chinese and ...
Crowdworks registers its first US patent
SEOUL, South Korea, Aug. 1, 2022 /PRNewswire/ -- Crowdworks (CEO Park Min-woo),
an Artificial Intelligence (AI) training data platform company, recently
announced that it had completed the registration of a US patent for 'Technology
for AI target training image sampling'.
Gracell Biotechnologies Appoints Accomplished Clinical Leader Dr. Wendy Li as Chief Medical Officer
Dr. Li brings deep oncology clinical development, medical affairs and U.S. regulatory experience SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, Aug. 1, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical compa...
Canadian Solar Inc. Completes its Continuance from the Jurisdiction of British Columbia to the Jurisdiction of Ontario
GUELPH, ON, Aug. 1, 2022 /PRNewswire/ -- Canadian Solar Inc.
Meihua International Medical Technologies Co., Ltd. Reports 2021 Financial Year Results
YANGZHOU, China, Aug. 1, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today reported its financial res...
Silicon Photonics Unlock New Architecture For 400G Data Center
SHENZHEN, China, Aug. 1, 2022 /PRNewswire/ -- FIBERSTAMP is proud to release the 400G data center interconnect architecture based on silicon photonics transceivers. Currently, what the interconnection scenarios within 2 kilometers of 400G data centers mainly deployed are the 400G QSFP-DD DR4 tran...
NTX™ Gears up for Growth with a Nearly US$200 Million in C2 Round Financing Led by Centurium Capital
Ramps up for Further Southeast Asia Expansion Following Partnership with Industry LeaderLuen Thai and Launch of State-of-the-Art NTX™ Cooltrans™ Facility inCambodia SHANGHAI and SINGAPORE, July 31, 2022 /PRNewswire/ -- NTX™, a global textile technology leader, announced the completion of nearly2...
Yalla Group Announces Board Changes
DUBAI, UAE, Aug. 1, 2022 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the leading voice-centric social networking and entertainment platform in theMiddle East and North Africa (MENA), today announced that following a rigorous selection process, Mr.Mohamed Al Ghanim...
VivaCut, a "gathering place" for short video creators
NEW YORK, Aug. 1, 2022 /PRNewswire/ -- Since the COVID-19 pandemic, the creator economy has become extraordinarily prosperous. According to a report inNew York Times in July last year, more than 50 million content creators from all over the world worked in the digital space, making money online t...
Eccogene Announces US IND Approval for THRβ agonist ECC4703
SHANGHAI, Aug. 1, 2022 /PRNewswire/ -- Eccogene announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to commence Phase I trial of its thyroid hormone receptor agonist ECC4703 in U.S. This study will evaluate the safety, tolerabilit...
Nippon Express (China) Opens New Healthcare Branch in Shanghai
- Company Is Stepping up Its Efforts in China's Pharmaceutical Industry - TOKYO, Aug. 1, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a Healthcare Branch inShanghai to strengthen its efforts in Chin...
Nippon Express (China) Opens New Healthcare Branch in Shanghai
- Company Is Stepping up Its Efforts in China's Pharmaceutical Industry - TOKYO, Aug. 1, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a Healthcare Branch inShanghai to strengthen its efforts in Chin...
Week's Top Stories
Most Reposted
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 275 media titles]
2026-10-21 15:00DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 270 media titles]
2026-10-22 11:55Carro Establishes Inaugural SGD450 Million Asset-Backed Securitisation Warehouse Facility
[Picked up by 267 media titles]
2026-10-22 11:00Ready Server Launches ReadyServer LLM API, Giving Every VPS Customer Private AI Inference at No Extra Cost
[Picked up by 265 media titles]
2026-10-20 14:10